Excedrin
- Product NDC
- 85237-1868
- 11-digit product format
- 852371868
- Labeler code
- 85237
- Product ID
- 85237-1868_46fa8b27-fe58-4382-e063-6394a90a8965
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin (NSAID), Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Select Consumer Group
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-01-01
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Excedrin
- Brand name suffix
- Extra Strength Headache
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3caa0a47-de83-90d2-e063-6394a90a3436 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1868-1 | ExcedrinExtra Strength Headache | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 3 | |
| 85237-1868-1 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-2 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-2 | ExcedrinExtra Strength Headache | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-3 | ExcedrinExtra Strength Headache | 25 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 25 | 3 | |
| 85237-1868-3 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-6 | ExcedrinExtra Strength Headache | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 85237-1868-6 | ExcedrinExtra Strength Headache | 50 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 50 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Goodys Cool Orange Headache | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | Medtech Products Inc. | 31212c97-9975-427e-bc3d-f7125f30299a | 2025-10-23 | Warnings | M013 |
| BC Arthritis | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | 2025-10-23 | Warnings | M013 |
| Goodys Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | d4325b17-23bc-44ac-868d-bb0886853a73 | 2025-10-23 | Warnings | M013 |
| BC | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 226173d4-b6d5-4fe6-b24e-1cc5d1b31c88 | 2025-10-23 | Warnings | M013 |
| BC MAX | ASPIRIN, ACETAMINOPHEN, CAFFEINE | Medtech Products Inc. | 1e2a07ab-23e6-49b4-a676-212dc6880f14 | 2025-10-23 | Warnings | M013 |
| Ecotrin Regular Strength | ASPIRIN | Medtech Products Inc. | 36cb530b-25b2-4f62-a25d-aa04360815a8 | 2025-10-23 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | TOPCO ASSOCIATES LLC | bbc367cc-6c79-498e-8fca-1347e6ea1a8c | 2025-10-22 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | b16ed4ef-689c-4df2-ab6c-207aa8b9925d | 2025-10-22 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | TIME CAP LABS INC | 05364eb4-07a1-a4d9-e063-6294a90a47e5 | 2025-10-21 | Warnings | M013 |
| Acetaminophen, Aspirin, Caffeine | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy, Inc. | 6deb854f-863e-24ad-e053-2991aa0afb17 | 2025-10-21 | Warnings | M013 |
| BackAid | ACETAMINOPHEN, CAFFEINE | Kobayashi Healthcare International, Inc. | 25db6bb5-96b6-4be1-e063-6294a90a2300 | 2025-10-21 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | Method Pharmaceuticals, LLC | 1539dc44-15a0-153b-e063-6294a90a9d45 | 2025-10-21 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | Method Pharmaceuticals, LLC | 3d1bb61c-15db-4eba-aba9-cfbcbc7b30e0 | 2025-10-21 | Warnings | M013 |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | M013 |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | M013 |
| Xesso Neo | BENZOCAINE | PREMIUM NATURAL COSMETICS INC | 163f32cd-4e51-950a-e063-6394a90a4816 | 2025-10-17 | Warnings | M013 |
| Menstrual Complete Maximum Strength | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | CHAIN DRUG MARKETING ASSOCIATION INC | 913d8bdb-7644-464c-b9a6-55387ff12059 | 2025-10-17 | Warnings | M013 |
| Alka-Seltzer Hangover Relief | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | dc235b06-999e-221d-e053-2a95a90a0ce1 | 2025-10-16 | Warnings | M013 |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 41386de5-5857-efab-e063-6294a90afd9c | 2025-10-15 | Warnings | M013 |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 4138d4c0-baa5-1f20-e063-6394a90a788f | 2025-10-15 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 209468 | EXCEDRIN 250 MG / 250 MG / 65 MG Oral Tablet | PSN | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 209468 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin] | SBD | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 209468 | APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin] | SY | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 209468 | Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 209468 | Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
| 209468 | Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 3caa0a47-de83-90d2-e063-6394a90a3436 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 85237-1868-1 | 85237186801 | 1 POUCH in 1 BLISTER PACK (85237-1868-1) / 2 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2024-01-01 | No | No | Current |
| 85237-1868-2 | 85237186802 | 2 POUCH in 1 BLISTER PACK (85237-1868-2) / 2 TABLET, FILM COATED in 1 POUCH | 2 pouch | 2024-01-01 | No | No | Current |
| 85237-1868-3 | 85237186803 | 25 POUCH in 1 BOX, UNIT-DOSE (85237-1868-3) / 2 TABLET, FILM COATED in 1 POUCH | 25 pouch | 2025-12-24 | No | No | Current |
| 85237-1868-6 | 85237186806 | 50 POUCH in 1 BOX, UNIT-DOSE (85237-1868-6) / 2 TABLET, FILM COATED in 1 POUCH | 50 pouch | 2025-12-24 | No | No | Current |